GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · IEX Real-Time Price · USD
8.50
+0.44 (5.46%)
At close: Jul 19, 2024, 4:00 PM
8.51
+0.01 (0.12%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $3.19 billion as of July 22, 2024. Its market cap has increased by 53.65% in one year.
Market Cap
3.19B
Enterprise Value
3.37B
1-Year Change
53.65%
Ranking
Category
Stock Price
$8.50
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $3.19B, a decrease of -74.83%. That is a compound annual growth rate of -30.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.19B | 17.20% |
| Dec 29, 2023 | 2.72B | 47.39% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.20% |
| Dec 31, 2020 | 15.74B | 24.23% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 3.30B |
| TG Therapeutics | 3.25B |
| Xenon Pharmaceuticals | 3.22B |
| Inari Medical | 3.19B |
| Amedisys | 3.19B |
| Biohaven Pharmaceutical Holding Company | 3.18B |
| Twist Bioscience | 3.14B |
| ADMA Biologics | 3.10B |